Literature DB >> 11416243

Acute effect of nasal continuous positive air pressure on the ventilatory control of patients with obstructive sleep apnea.

S M Moura1, L R Bittencourt, M C Bagnato, S R Lucas, S Tufik, L E Nery.   

Abstract

BACKGROUND: Sleep fragmentation can decrease the awake ventilatory control. Since patients with obstructive sleep apnea (OSA) patients exhibit sleep fragmentation linked to respiratory events, their ventilatory control could be impaired. However, most of these patients are also obese, which could conversely increase the ventilatory control. The effect of nasal continuous positive airway pressure (CPAP) on the awake ventilatory control in normocapnic OSA patients is unclear.
OBJECTIVES: To study the acute effect of nasal CPAP on the awake ventilatory control in normocapnic OSA patients.
METHODS: 12 normocapnic OSA patients, with an apnea/hypopnea index (AHI) >15 with moderate obesity (body mass index: 33.5 kg/m2) and normal pulmonary function tests were submitted to two polysomnography studies (diagnostic and for CPAP titration). Before and after 3 consecutive nights of nasal CPAP we analyzed the hypersomnia score and the ventilatory and the mouth occlusion pressure (P.1) responses at rest (breathing room air and a mixture of 8% CO2 + 40% O2).
RESULTS: The respiratory drive of OSA patients as evaluated by P.1 was in the range of the controls of our laboratory. After nasal CPAP, a significant decrease in AHI (mean: 51.9-9.4/h) and arousal (mean: 88.7-43/h) occurred, as well as improvement in nocturnal oxyhemoglobin. There was a marginal increase in DeltaV(E)/DeltaP(ET)CO2 (mean: 1.41-1.87 liters/min/ mm Hg, p = 0.09) and a significant rise in P.1/DeltaP(ET)CO2 (mean: 0.29-0.43 cm H2O/mm Hg), a better indicator of ventilatory drive.
CONCLUSIONS: Normocapnic OSA patients increased their awake ventilatory drive response to a hypercapnic and hyperoxic mixture with the use of 3 consecutive nights of nasal CPAP. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11416243     DOI: 10.1159/000050505

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

1.  Effects of exercise training associated with continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome.

Authors:  Carolina Ackel-D'Elia; Antonio Carlos da Silva; Rogério Santos Silva; Eveli Truksinas; Bolivar Saldanha Sousa; Sérgio Tufik; Marco Túlio de Mello; Lia Rita Azeredo Bittencourt
Journal:  Sleep Breath       Date:  2011-07-30       Impact factor: 2.816

2.  Randomized controlled trial of noninvasive positive pressure ventilation (NPPV) versus servoventilation in patients with CPAP-induced central sleep apnea (complex sleep apnea).

Authors:  Dominic Dellweg; Jens Kerl; Ekkehard Hoehn; Markus Wenzel; Dieter Koehler
Journal:  Sleep       Date:  2013-08-01       Impact factor: 5.849

3.  DNA damage in peripheral blood lymphocytes from patients with OSAHS.

Authors:  Jing Xie; Jianzhong Jiang; Keyun Shi; Tingting Zhang; Taofeng Zhu; Hong Chen; Ruhua Chen; Liming Qi; Weiliang Ding; Qiyi Yi; Tieliang Ma
Journal:  Sleep Breath       Date:  2014-01-29       Impact factor: 2.816

4.  Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired?

Authors:  Andrea Loewen; Michele Ostrowski; John Laprairie; Raj Atkar; January Gnitecki; Patrick Hanly; Magdy Younes
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

5.  Association between ventilatory response to hypercapnia and obstructive sleep apnea-hypopnea index in asymptomatic subjects.

Authors:  David Wang; Ronald R Grunstein; Harry Teichtahl
Journal:  Sleep Breath       Date:  2007-06       Impact factor: 2.655

6.  Mechanisms of improvement of respiratory failure in patients with COPD treated with NIV.

Authors:  Annabel H Nickol; Nicholas Hart; Nicholas S Hopkinson; Carl-Hugo Hamnegård; John Moxham; Anita Simonds; Michael I Polkey
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.